| Literature DB >> 34226038 |
Marianne Agerskov1, Anna N W Thusholdt2, Henrik Holm-Sørensen3, Sebastian Wiberg2, Christian S Meyhoff4, Jakob Højlund2, Niels H Secher5, Nicolai B Foss2.
Abstract
BACKGROUND: We hypothesised that in acute high-risk surgical patients, a lower intraoperative peripheral perfusion index (PPI) would indicate a higher risk of postoperative complications and mortality.Entities:
Keywords: cardiac output; clinical monitoring; gold-directed therapy; haemodynamics; peripheral perfusion index; postoperative complications; surgery
Mesh:
Year: 2021 PMID: 34226038 PMCID: PMC8451236 DOI: 10.1016/j.bja.2021.06.004
Source DB: PubMed Journal: Br J Anaesth ISSN: 0007-0912 Impact factor: 9.166
Fig 1Patients undergoing acute major abdominal or hip fracture surgery from November 2017 to October 2018 at Hvidovre and Bispebjerg University Hospitals, Copenhagen, Denmark. PPI, peripheral perfusion index.
Intraoperative haemodynamic variables, anaesthetic methods, vasoactive medication, fluid use, and outcome in acute high-risk abdominal and hip fracture patients.
| All | General anaesthesia | Neuraxial anaesthesia | ||
|---|---|---|---|---|
| Peripheral perfusion index | 3.3 (2.6) | 3.9 (2.8) | 2.5 (2.1) | <0.001 |
| Mean PPI ≤0.5 | 103 (8) | 34 (4) | 69 (12) | <0.001 |
| Mean PPI ≤1.5 | 397 (30) | 165 (21) | 232 (41) | <0.001 |
| Cumulated min with PPI ≤0.5 | 20 (38) | 13 (33) | 28 (43) | <0.001 |
| Cumulated min with PPI ≤1.5 | 54 (61) | 42 (59) | 71 (60) | <0.001 |
| MAP (mm Hg) | 69 (9) | 68 (9) | 71 (10) | <0.001 |
| Mean MAP ≤65 | 448 (34) | 271 (35) | 177 (31) | 0.2 |
| Cumulated min with MAP ≤65 | 62 (52) | 67 (52) | 56 (51) | <0.001 |
| HR (beats min−1) | 77 (14) | 76 (15) | 79 (13) | <0.001 |
| SpO2 (%) | 99 [97–100] | 99 [98–100] | 98 [96–100] | <0.001 |
| Temp (°C) | 36.7 (0.7) | 36.7 (0.7) | 36.8 (0.7) | 0.2 |
| Haemoglobin (mmol L−1) | 6.9 (1.3) | 7.0 (1.3) | 6.6 (1) | <0.001 |
| Lactate (mmol L−1) | 0.9 [0.7–1.3] | 0.9 [0.7–1.4] | 0.9 [0.6–1.2] | 0.01 |
| Duration of surgery (min) | 82 [60–118] | 92 [64–135] | 76 [58–96] | <0.001 |
| Volatile anaesthetic | 208 (27) | 208 (27) | – | – |
| Total intravenous anaesthesia | 561 (73) | 561 (73) | – | – |
| Thoracic epidural blockade | 284 (37) | 284 (37) | – | – |
| Sedation | 389 (69) | – | 389 (69) | – |
| Inotropes | 47 (2) | 45 (6) | 2 (0.4) | <0.001 |
| Infusion vasopressor∗ | 502 (38) | 392 (51) | 110 (19) | <0.001 |
| Blood products | 213 (16) | 129 (17) | 84 (15) | 0.4 |
| Fluids† (ml) | 1301 (900) | 1350 (1012) | 800 (514) | <0.001 |
| Blood loss (ml) | 100 [0–300] | 75 [0–250] | 200 [50–300] | <0.001 |
| Clavien–Dindo Class ≥III | 325 (24) | 241 (31) | 84 (15) | <0.001 |
| 30-Day mortality | 139 (10) | 97 (17) | 42 (7) | <0.001 |
| 90-Day mortality | 234 (18) | 148 (19) | 86 (15) | 0.07 |
| LOS (days) | 8 [5–12] | 8 [5–13] | 8 [5–11] | 0.06 |
| Readmissions | 387 (30) | 228 (31) | 159 (29) | 0.4 |
Data are presented as [inter-quartile range], mean (standard deviation) or n (%). ∗Phenylephrine, noradrenaline, or both. †Ringer's acetate, Ringer's lactate, NaCl, HA, human albumin; Voluven®, or any combination of these. LOS, length of stay; SpO2: peripheral capillary oxygen saturation; Temp, temperature.
Fig 2Percentage Clavien–Dindo Class ≥III and 30-day mortality according to mean intraoperative PPI in patients undergoing acute high-risk abdominal or hip fracture surgery. PPI, peripheral perfusion index.
Univariable association between potential risk factors/confounders with the primary outcome of severe postoperative complications: Clavien–Dindo Class ≥III within 30 days in acute high-risk abdominal and hip fracture patients.
| All | General anaesthesia | Neuraxial anaesthesia | ||||
|---|---|---|---|---|---|---|
| PPI, per 1.0 decrease in mean PPI | 1.07 (1.02–1.13) | 0.01 | 1.13 (1.07–1.21) | <0.001 | 1.13 (1–1.29] | 0.07 |
| Mean PPI ≤0.5, yes | 1.67 (1.08–2.55) | 0.02 | 3.33 (1.66–6.84) | 0.001 | 1.72 (0.89–3.15) | 0.09 |
| Mean PPI ≤1.5, yes | 1.36 (1.04–1.78) | 0.002 | 2 (1.40–2.85) | <0.001 | 1.45 (0.91–2.31) | 0.1 |
| PPI ≤0.5, per 15 min | 1.08 (1.03–1.13) | <0.001 | 1.17 (1.09–1.26) | <0.001 | 1.1 (1.02–1.18) | 0.01 |
| PPI ≤1.5, per 15 min | 1.04 (1.01–1.07) | 0.01 | 1.08 (1.04–1.12) | <0.001 | 1.05 (0.99–1.11) | 0.1 |
| Mean MAP ≤65, yes | 1.21 (0.92–1.58) | 0.2 | 0.79 (0.57–1.09) | 0.2 | 0.8 (0.47–1.33) | 0.4 |
| MAP ≤65, per 15 min | 1.04 (1–1.08) | 0.04 | 1.03 (1–1.08) | 0.2 | 1.02 (0.95–1.1) | 0.6 |
| Surgery, AHA | 3.74 (2.89–4.87) | <0.001 | 3.36 (2.39–4.79) | <0.001 | – | – |
| Infusion vasopressor, yes | 2.49 (1.93–3.21) | <0.001 | 2.29 (1.67–3.14) | <0.001 | 1.36 (0.77–2.33) | 0.3 |
| Fluids∗, per 100 ml | 1.07 (1.05–1.08) | <0.001 | 1.06 (1.05–1.08) | <0.001 | 1.01 (1–1.05) | 0.7 |
| Blood loss, per 100 ml | 1.06 (1.04–1.09) | <0.001 | 1.06 (1.03–1.1) | <0.001 | 1.07 (1.02–1.14) | 1.01 |
| Age, per yr | 1 (1–1.01) | 0.9 | 1 (0.99–1.01) | 0.7 | 1.03 (1.01–1.06) | 0.001 |
| Sex, male | 1.31 (1.02–1.69) | 0.03 | 1.19 (0.87–1.62) | 0.3 | 1.12 (0.88–2.27) | 0.2 |
| ASA physical status ≥3, yes | 2.05 (1.58–2.68) | <0.001 | 1.74 (1.27–2.4) | 0.001 | 2.96 (1.78–5.11) | <0.001 |
| Zubrod score ≥III, yes | 2.6 (1.83–3.68) | <0.001 | 2.14 (1.41–3.23) | <0.001 | 3.16 (1.59–6.05) | 0.001 |
| CCI, per 1 increase in index | 1.14 (1.08–1.2) | <0.001 | 1.1 (1.04–1.16) | 0.001 | 1.28 (1.15–1.43) | <0.001 |
Odds ratio (95% confidence interval). AHA, acute high-risk abdominal surgery; ASA, American Society of Anesthesiologists; CCI, Charlson Comorbidity Index; PPI, peripheral perfusion index. ∗Ringer's acetate, Ringer's lactate, NaCl, HA, Voluven®, or any combination of these.
Univariable and multivariable association of PPI with severe postoperative complications Clavien–Dindo Class ≥III within 30 days and 30-day mortality in acute high-risk abdominal and hip fracture patients.
| PPI, per 1.0 decrease in mean PPI | 1.07 (1.02–1.13) | 0.01 | 1.12 (1.05–1.19) | <0.001 |
| Mean PPI ≤0.5, yes | 1.67 (1.08–2.55) | 0.02 | 1.79 (1.09–2.91) | 0.02 |
| Mean PPI ≤1.5, yes | 1.36 (1.04–1.78) | 0.002 | 1.65 (1.2–2.27) | 0.002 |
| PPI ≤0.5, per 15 min | 1.08 (1.03–1.13) | <0.001 | 1.11 (1.05–1.17) | <0.001 |
| PPI ≤1.5, per 15 min | 1.04 (1.01–1.07) | 0.01 | 1.06 (1.02–1.09) | 0.002 |
| PPI, per 1.0 decrease in mean PPI | 1.25 (1.14–1.37) | <0.001 | 1.2 (1.08–1.34) | 0.001 |
| Mean PPI ≤0.5, yes | 2.25 (1.3–3.74 | 0.002 | 1.94 (1.04–3.48) | 0.03 |
| Mean PPI ≤1.5, yes | 2.21 (1.55–3.16) | <0.001 | 2.07 (1.37–3.14) | 0.001 |
| PPI ≤0.5, per 15 min | 1.16 (1.1–1.22) | <0.001 | 1.16 (1.09–1.24) | <0.001 |
| PPI ≤1.5, per 15 min | 1.09 (1.05–1.14) | <0.001 | 1.09 (1.04–1.14) | <0.001 |
∗Adjusted for: comorbidities; ASA physical status ≥3, Zubrod score ≥III, Charlson Comorbidity Index, age, sex, type of anaesthesia, type of surgery, i.v. fluid administration, blood loss, MAP ≤65 mm Hg. CI, confidence interval; OR, odds ratio.
Fig 3Effect of time below/above predetermined thresholds of mean intraoperative peripheral perfusion index in patients undergoing (a) general anaesthesia and (b) neuraxial anaesthesia.